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Staphylococcus aureus produces membrane-derived vesicles (MVs), which share
functional properties to outer membrane vesicles. Atomic force microscopy revealed
that S. aureus-derived MVs are associated with the bacterial surface or released into
the surrounding environment depending on bacterial growth conditions. By using a
comparative proteomic approach, a total of 131 and 617 proteins were identified in
MVs isolated from S. aureus grown in Luria-Bertani and brain-heart infusion broth,
respectively. Purified S. aureus MVs derived from the bacteria grown in either media
induced comparable levels of cytotoxicity and neutrophil-activation. Administration of
exogenous MVs increased the resistance of S. aureus to killing by whole blood or
purified human neutrophils ex vivo and increased S. aureus survival in vivo. Finally,
immunization of mice with S. aureus-derived MVs induced production of IgM, total IgG,
IgG1, IgG2a, and IgG2b resulting in protection against subcutaneous and systemic
S. aureus infection. Collectively, our results suggest S. aureus MVs can influence
bacterial–host interactions during systemic infections and provide protective immunity
in murine models of infection.
Keywords: Staphylococcus aureus, membrane-derived vesicles, proteomics, systemic infection, protective
immunity
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INTRODUCTION
Many pathogenic Gram-negative bacteria species extend their
virulence potential by releasing spherical buds, derived from
the outer membrane, so-called outer membrane vesicles (OMVs;
reviewed in Bomberger et al., 2009; Kulp and Kuehn, 2010;
Kaparakis-Liaskos and Ferrero, 2015; Yáñez-Mó et al., 2015).
OMVs play an essential role in the long-distance delivery of
intact bacterial effectors (Kuehn and Kesty, 2005; Mashburn and
Whiteley, 2005; Schooling and Beveridge, 2006; Ellis and Kuehn,
2010; Kulp and Kuehn, 2010; Gurung et al., 2011; Jun et al., 2013;
Nho et al., 2015; Jeon et al., 2016) by protecting the cargo against
the harsh extracellular environment (reviewed in Bomberger
et al., 2009; Kulp and Kuehn, 2010; Kaparakis-Liaskos and
Ferrero, 2015; Schwechheimer and Kuehn, 2015; Yáñez-Mó et al.,
2015). The release of OMVs can benefit the microbe, mediating
key microbial interactions with the human host and within
bacterial communities (reviewed in Bomberger et al., 2009; Kulp
and Kuehn, 2010; Kaparakis-Liaskos and Ferrero, 2015; Yáñez-
Mó et al., 2015). Diverse functions ascribed to OMVs, even in
the absence of live bacterial cells, include promotion of virulence,
biofilm formation, signal transduction, cytotoxicity, and host
pathology (Kuehn and Kesty, 2005; Mashburn and Whiteley,
2005; Schooling and Beveridge, 2006; Ellis and Kuehn, 2010; Kulp
and Kuehn, 2010; Gurung et al., 2011; Jun et al., 2013; Brown
et al., 2015; Nho et al., 2015; Jeon et al., 2016). Furthermore,
OMVs contain various pathogen-associated molecular patterns,
which can modulate the host pro- and/or anti-inflammatory
responses (reviewed in Kuehn and Kesty, 2005; Kaparakis-
Liaskos and Ferrero, 2015; Schwechheimer and Kuehn, 2015)
and subsequently influence recruitment of immune cells to sites
of inflammation (reviewed in Lee, 2012; Kaparakis-Liaskos and
Ferrero, 2015; Schwechheimer and Kuehn, 2015).
In recent years, several Gram-positive bacteria and
mycobacteria such as Staphylococcus aureus, Mycobacterium
ulcerans, Mycobacterium tuberculosis, Mycobacterium bovis
bacilli, Bacillus spp., Streptococcus spp., Clostridium perfringens,
and Listeria monocytogenes have been found to produce
membrane-derived vesicles (MVs) during in vitro culture
and/or in vivo murine infection (Marsollier et al., 2007; Lee
et al., 2009; Lee J.H. et al., 2013; Rivera et al., 2010; Gurung
et al., 2011; Hong et al., 2011; Prados-Rosales et al., 2011;
Thay et al., 2013; Jiang et al., 2014; Haas and Grenier, 2015;
Resch et al., 2016). Thus, vesicle generation may be considered
a ubiquitous conserved secretory pathway among bacteria
(Gurung et al., 2011; Lee, 2012). In Gram-negative bacteria,
a phospholipid transporter was found to be associated with
OMV formation (Roier et al., 2016). For Gram-positive
bacteria it has been hypothesized that the membrane and
luminal contents of MVs are derived from the cytoplasmic
membrane and cytoplasm, respectively (Kato et al., 2002;
MacDonald and Kuehn, 2012; Yáñez-Mó et al., 2015). Recently,
a prophage-triggered mechanism noted to endolysin expression
and consequently peptidoglycan damage was identified as a
putative mechanism for MV formation in the Gram-positive
model organism, Bacillus subtilis (Toyofuku et al., 2017).
However, the exact mechanism of MV biogenesis and transport
through the thick cell wall of Gram-positive bacteria remains
unknown.
Staphylococcus aureus can cause a wide array of invasive
human diseases due to its ability to disarm the innate immune
system with an extensive armamentarium of immune evasion
factors (Foster et al., 2014). The pathogen is the most common
cause of hospital-acquired infections, while community-acquired
S. aureus infections are rapidly emerging as a public health
problem (reviewed in Foster, 2009). Previous in vitro studies
indicate that MVs play a critical role in the delivery of S. aureus
toxins into host cells via interactions with the cholesterol-rich
micro-domains of the host cell plasma membranes, whereupon
host cell death may ensue (Gurung et al., 2011; Thay et al.,
2013). Besides, S. aureus-derived MVs produce biofilm formation
(He et al., 2017) and harbor biologically active β-lactamases,
thwarting antibiotic effectiveness extracellularly (Lee J. et al.,
2013). The potential role for S. aureus MVs in provoking atopic
dermatitis-like skin (Hong et al., 2011; Jun et al., 2017) and
neutrophilic pulmonary (Kim et al., 2012) inflammation have also
been described.
Previous studies have revealed S. aureus-derived MVs carry
a complex arsenal of virulence factors (Lee et al., 2009; Gurung
et al., 2011; Jeon et al., 2016). However, the potential role
that MVs play in S. aureus pathogenesis remains incompletely
or poorly characterized. Furthermore, whether bacterial growth
conditions influence MV cargo, and downstream host responses
to MV exposure, are not yet understood. In this study,
we examined the interactions between exogenously derived
S. aureus MVs with several immune processes. Moreover, the
immunogenic properties of S. aureus MVs and their ability to
confer protection in murine models of sepsis and skin infection
were also explored.
MATERIALS AND METHODS
Bacterial Strains and Mammalian Cell
Lines
Staphylococcus aureus subsp. aureus Rosenbach MSSA476
was purchased from LGC standard AB (ATCC- BAA-1721,
Sweden), while S. aureus USA300-MRSA (TCH1516, ATCC
BAA-1717) and its isogenic mutant USA300-MRSA1Hla
were provided by Prof. V. Nizet. Keratinocytes (HaCaT
cells; Boukamp et al., 1988) and monocytes (THP-1 cells)
were purchased from PromoCell (Germany) and ATCC
(United States), respectively. HaCaT cells were maintained in
Dulbecco’s modified Eagle’s medium (Sigma–Aldrich, Germany),
supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen
Life Technologies, United States), penicillin (100 units/ml), and
100 µg/ml streptomycin (Sigma–Aldrich, Germany) in a CO2
incubator (5% CO2) at 37◦C. THP-1 cells were maintained
in RPMI 1640 medium with 2 mM L-glutamine (Gibco, Life
Technologies, United Kingdom) supplemented with 10% (v/v)
FBS, 4.5 g/l glucose (Sigma–Aldrich, Germany), 10 mM HEPES
(Sigma–Aldrich, Germany), and 1.0 mM sodium pyruvate
(Sigma–Aldrich, Germany) supplemented with 0.05 mM
2-mercaptoethanol (Sigma–Aldrich, Germany).
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Atomic Force Microscopy (AFM)
Atomic force microscopy (AFM) analysis of S. aureus MSSA476
cultivated on Luria-Bertani (LB) agar (LA), brain-heart infusion
(BHI) agar, and blood agar were carried out as described
previously (Thay et al., 2013). Briefly, bacterial cells were
suspended in ultrapure water and placed on a freshly cleaved mica
surface. The samples were incubated for approximately 5 min
at room temperature and blotted dry before being placed into a
desiccator. Representative images were collected by a Nanoscope
V Atomic Force Microscope (Bruker AXS, Germany).
Transmission Electron Microscopy (TEM)
Staphylococcus aureus MSSA476 was cultivated on LA plate. The
bacterial pellet was carefully resuspended in 0.1 M phosphate
buffer pH 7.4. Thereafter, 1.5 µl of the sample was applied
to glow-discharged, 300 mesh, copper grids for 1.5 min and
quickly washed in two drops of phosphate buffer. Bacterial cells
were briefly fixed in 2% paraformaldehyde in phosphate buffer.
Grids were blocked with 0.5% cold fish skin gelatin (Sigma,
Stockholm, Sweden) diluted in phosphate buffer, incubated with
anti-Staphylococcus aureus antibody (Abcam, ab20002), which
specifically recognizes an epitope of peptidoglycan. The primary
antibody was diluted in blocking solution (1:30), washed in
phosphate buffer and incubated in blocking solution (1:25) with
10 nm protein A-gold (Cell Microscopy Core, Utrecht). Grids
were washed in MQ water, briefly fixed with 2.5% glutaraldehyde
and washed before they were negatively stained with 1.5%
uranyl acetate (TAAB, Berks, United Kingdom), 2 × 15 s
(vesicles) and 20 s (bacterial cells). Samples were examined with
Talos 12◦C (FEI, Eindhoven, Netherlands) operating at 120 kV.
Micrographs were acquired with a Ceta 16M CCD camera
(FEI, Eindhoven, Netherlands) using transmission electron
microscopy (TEM) Image and Analysis software ver. 4.15 (FEI,
Eindhoven, Netherlands).
The negative-stain TEM analysis on the purified MVs was
performed as previously described (Resch et al., 2016), with
minor modification. Briefly, 5–6 µl of purified MVs were placed
on Formvar-coated, 75 mesh, copper grids for 5 min at room
temperature. The sample was quickly washed with ultrapure
water (4×, 1–2 min each). Negative staining was performed
using 2% methylcellulose and 3% uranyl acetate for 2 min on
ice. The excess stain was removed, and the sample was allowed
to dry. Imaging was performed using JEOL JEM 1010 (JEOL,
United States) operating at 80 kV. A grid treated for TEM
visualization in the absence of MVs, served as negative control.
Isolation, Fractionation, and
Quantification of MVs
Staphylococcus aureus MSSA476, USA300 MRSA, and its isogenic
mutant USA300 MRSA1Hla were grown overnight at 37◦C in
LB and/or BHI broth. MVs were isolated from the overnight
culture (diluted 1:100 and grown for 12–14 h). A pilot study
was performed to evaluate whether media choice influenced
the viability of S. aureus. Analysis of S. aureus viability was
performed using propidium iodide (PI) staining (Invitrogen
Life Technologies, United States) and flow cytometry. S. aureus
treated with gentamicin (100 µg/ml) and lysostaphin (40 µg/ml)
for 2 h at 37◦C with shaking was stained with PI, and served as
a positive control (Supplementary Figure 1). MVs were isolated
and purified as previously described (Kim et al., 2012; Thay et al.,
2013; Choi et al., 2015), with minor modifications. Briefly, the
culture supernatants were prepared by centrifuging the bacterial
cultures at 6,000 × g for 20 min at 4◦C using a JLA 10-500
rotor (Beckman Coulter, United States) and filtered through
0.22-µm vacuum-bottle top filters (Millipore, United States).
Filtration was performed to remove bulk bacterial cells and cell
debris (Choi et al., 2017). The bacteria-free supernatant was
then centrifuged at 100,000 × g at 4◦C for 3–4 h in either
45 or 50.2 Ti rotors (Beckman Instruments, Inc.). The MVs
pellet was washed twice with PBS as described previously (Lee
J. et al., 2013; Fulsundar et al., 2014; Choi et al., 2015; Resch
et al., 2016), centrifuged at 100,000 × g at 4◦C for an extra
3–4 h and finally re-suspended in PBS (Biochrom, Germany).
The protein content of the isolated MVs was measured using
a Direct DetectorTM (Millipore, United States). The sterility
of the isolated MVs was examined by streaking small aliquots
on blood/BHI agar plates followed by overnight incubation at
37◦C.
In order to perform proteomic analysis, fractionation of
MVs from S. aureus MSSA476 grown in LB and BHI broth
was carried out by density gradient centrifugation using
Optiprep (Sigma–Aldrich, Germany) as previously described
(Elluri et al., 2014), with minor modifications. Briefly, different
Optiprep/ultrapure water layers were sequentially added to the
tube as follows: 400 µl (45%), 600 µl (35%), 600 µl (30%),
600 µl (25%), 600 µl (20%), 500 µl (15%), and 400 µl (10%).
Finally, 400 µl of isolated MVs was loaded on top of the
gradient followed by centrifugation at 180,000 × g for 3 h
at 4◦C using an SW60Ti rotor (Beckman Instruments Inc.,
United States). Thereafter, 200 µl aliquots were sequentially
harvested and analyzed by SDS-PAGE followed by Coomassie
Blue staining. Fractions showing the same protein profile on
Coomassie gel were pooled, and the purity of the MVs was
verified by negative-stain TEM and/or AFM imaging (examples
are shown in Supplementary Figures 2, 3B). Finally, the amount
of MVs was quantified using Pierce BCA Protein Assay Kit
(Thermo Fisher Scientific, United States) or Direct DetectorTM
according to the manufacturer’s instructions.
Dynamic Light Scattering (DLS)
Particle size distribution of S. aureus-derived MVs was analyzed
at 25◦C using a Zetasizer Nano ZS particle analyzer (Malvern,
United Kingdom). The purified MVs were diluted to a final
concentration of approximately 10 µg/ml (protein) in PBS,
and the size was estimated. The results are represented
as the percentage of MVs with diameters measured in
nanometers (nm).
Lipid-Based Protein Immobilization (LPI)
and In-Solution Processing
The purity of the recovered fractions of MVs after Optiprep
was verified using AFM prior to further processing by
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Nanoxis Consulting AB1. For the proteomic analysis a digestion
protocol using two different approaches including the lipid-based
protein immobilization (LPI) Hexa Lane FlowCell (Karlsson
et al., 2012) and an in-solution (In-sol) protocol were
utilized. The LPI FlowCell system provides a novel platform
specifically for characterization of the membrane proteins.
Briefly, S. aureus-derived MVs were immobilized through
membrane–gold interactions, on the flow cell surface. After 1 h
incubation to ensure adhesion, the MVs were washed with PBS
and further subjected to trypsin digestion of surface-exposed
proteins in multiple steps. This process enhances sequence
coverage, and the generated peptides can be further analyzed with
mass spectrometry (MS) to identify the MV-associated proteins
(Chooneea et al., 2010; Karlsson et al., 2012).
In the LPI method, samples were injected into three different
LPI channels (40 µl in each channel) and immobilized on
the channel-surfaces. The wash step was performed using a
syringe pump by pumping through 400 µl (100 mM, pH
8.0) of tetraethylammonium bromide (TEAB) (Sigma–Aldrich,
Germany). Next, 100 µl of trypsin solution (2 µg/ml of
trypsin in ammonium bicarbonate, 20 mM, pH 8.0) were
added to each channel. The samples were then treated with
trypsin for 1 h to digest surface-associated proteins into
peptides. For the In-sol approach, 80 µl of the MV samples
were diluted in 40 µl PBS followed by the addition of glass
beads (150–212 µm; Sigma–Aldrich, Germany). Thereafter,
samples were processed with a bead-beating step prior to a
6 h In-sol digestion with 2 µg/ml of trypsin in ammonium
bicarbonate (20 mM, pH 8.0) at a 1:1 (sample to trypsin)
ratio. Next, the peptide samples were eluted with 200 µl of
TEAB by a syringe pump (100 µl/min) and collected for MS
analysis.
Peptide Sample Preparation and Liquid
Chromatography (LC) Gradient
The sample preparation was carried out by Nanoxis AB
(see text footnote 1) as described previously (Karlsson et al.,
2012), with minor modifications. PepClean C18 spin columns
(Thermo Fisher Scientific, United States) were used to desalt
the peptides according to the manufacturer’s instructions.
The columns were dried and reconstituted using 3% HPLC
grade acetonitrile (ACN) (Merck, Germany) supplemented
with 0.1% formic acid (Sigma–Aldrich, Germany). The sample
was injected on an Easy-nLC autosampler (Thermo Fisher
Scientific, United States) and analyzed with an interfaced Q
Exactive hybrid mass spectrometer (Thermo Fisher Scientific,
United States). The peptides were trapped on a pre-column
(45 mm × 0.075 mm i.d.) and separated on a reversed phase
analytical column (200 mm × 0.075 mm) packed in-house with
3 µm Reprosil-Pur C18-AQ particles (Dr. Maisch, Ammerbuch,
Germany). The nanoLC (liquid chromatography) gradient was
run at 200 nl/min as follow: 7–27% ACN supplemented with
0.2% formic acid during 25 min, 27–40% ACN during 5 min,
40–80% during 5 min, and finally hold at 80% ACN for
10 min.
1www.nanoxis.com
Mass Spectrometry (MS) Settings
MS was performed by Nanoxis and run in a data-dependent
positive ion mode. The ion spray voltage into the mass
spectrometer and capillary temperature were adjusted to 1.8 kV
and 320◦C. Full scan (MS1) spectra were acquired in the
Orbitrap over the m/z range 400–1,600, charge range 2–6 at
a resolution of 70,000 until an AGC target value of 1e6 with
a maximum injection time of 250 ms. MS/MS spectra were
acquired using higher energy collision dissociation at 30% from
m/z 110 for the 10 most abundant parent ions at a resolution
of 35,000 using a precursor isolation window of 2 Da with an
AGC target value of 100,000 and a maximum injection time of
110 ms. Dynamic exclusion during 30 s after selection for MS/MS
was enabled to allow for detection of as many precursors as
possible.
Bioinformatics Analysis
Raw data from the MS analysis was searched against NCBI
S. aureus MSSA4762 using the Sequest algorithm in Proteome
Discoverer version 2.1 (Eng et al., 1994). Data were filtered
to a 1% peptide and protein level false positive rate using
a reverse database approach (Elias and Gygi, 2007). The
area under the curve (AUC)-based label free quantitation
of detected proteins was determined through the Proteome
Discoverer workflow. Proteins commonly found in the two
groups (LB and BHI) and unique to each group were
classified according to biological processes, molecular functions,
and cellular components using DAVID (Huang et al., 2009),
respectively. Benjamini–Hochberg corrected p-value < 0.05 and
an FDR < 5% were accepted for gene ontology (GO) terms.
The computational prediction of the subcellular localization of
MV proteins was performed by PSORTb3 (Yu et al., 2010).
For the appropriate input, GI numbers were converted to
the UniProt ID. In total, 373 out of 639 MVs proteins were
mapped into UniProtKB ID. The breakdown by localization
is graphed as a pie chart. The UniProt ID was utilized to
extract the protein sequence. The lipoprotein, and secretory
signal peptides were predicted using PRED-LIPO4 (Bagos et al.,
2008).
Growth Curves of S. aureus MSSA476 in
the Presence and Absence of Exogenous
MVs
Staphylococcus aureus MSSA476 was grown overnight in tryptic
soy broth. The next day, the culture was diluted and further
grown in BHI and LB broth, washed in PBS, resuspended in
BHI and LB broth and added to honeycomb plates (Bioscreen,
United States) in a total volume of 200 µl. Purified MVs from
S. aureus MSSA476 grown in LB or BHI were administered at a
total concentration of 20 µg (0.1 µg/µl). Growth was monitored
by measuring OD600 nm every 15 min under shaking conditions
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Blood Survival Assay
The viability of S. aureus in whole human blood was assessed and
performed as previously described (Askarian et al., 2017). Briefly,
blood from healthy donors was collected in tubes containing
hirudin (lepirudin; Roche, Switzerland), which is a specific
inhibitor of thrombin thereby preventing coagulation without
impairing complement activity. Approximately 160 µl of freshly
drawn blood was mixed with 20 µl of S. aureus MSSA476
(∼8 × 106 CFU/ml) or MRSA USA300 (∼1 × 106 CFU/ml)
in RPMI 1640 (Gibco, Life Technologies, United Kingdom)
containing 0.05% human serum albumin (HSA; Sanquin,
Netherlands). Thereafter, 20 µl of buffer (RPMI/HSA) or 5–20 µg
MVs (0.025–0.1 µg/µl) in buffer was added to the blood with
bacteria-samples. When indicated, the MVs were sonicated,
left untreated or treated with 0.1 µg/ml proteinase K (PK;
Life Technologies, United Kingdom) for 3 h at 56◦C prior to
use. When indicated, the blood assay was performed in the
absence of MVs, presence of intact, sonicated or sonicated-PK
treated MVs for 3 h at 37◦C on a rotator. Blood cells were
lysed by adding 800 µl ice-cold H2O supplemented with 0.3%
saponin (Sigma–Aldrich, Germany). Bacterial survival in blood
was evaluated by serial dilution of blood with subsequent plating
on blood/Todd Hewitt agar (THA) plates following overnight
incubation at 37◦C. The percentage of bacterial survival was
determined by comparing surviving bacteria to the input
inoculum.
Neutrophil Isolation
Neutrophils were isolated from the heparinized venous blood of
healthy volunteers (see section “Ethical Approval”) using 1-Step
polymorphprep (Fresenius Kabi Norge AS, Norway) gradient
centrifugation.
Neutrophil Killing Assay
The assay was performed as previously described using freshly
isolated neutrophils (Askarian et al., 2017). Briefly, bacteria were
opsonized with 5% serum and incubated with neutrophils in
RPMI/HSA at an MOI = 1.5 or MOI = 10. Thereafter, 20 µg of
MVs (0.1 µg/µl), purified from bacteria grown in LB or BHI was
added to the assay when indicated. The neutrophils and bacteria,
in presence or absence of MVs were incubated at 37◦C on a
rotator. After 45 min, neutrophils were lysed using 800 µl of ice
cold H2O supplemented with 0.3% saponin followed by 5 min
incubation on ice. Surviving bacteria were quantified following
serial dilution and plating on THA plates. The percentage of
bacterial survival was determined by comparing the numbers of
surviving bacteria to the input inoculum.
Whole Blood Phagocytosis
Fluorescent-labeling of bacteria was performed using 0.5 mg/ml
FITC (Sigma–Aldrich, Germany) as previously described
(Askarian et al., 2017). Next, 20 µl of FITC-labeled S. aureus
MSSA476 (∼1 × 108 CFU/ml) was incubated for 15 min at
37◦C with 160 µl of freshly isolated human blood anticoagulated
with hirudin in RPMI/HSA. When indicated, 20 µg of purified
MVs (0.1 µg/µl) were added to the samples. The red blood cells
were lysed by adding FACS lysing solution (BD Biosciences,
United States). The remaining cells (primarily neutrophils)
were washed and analyzed by flow cytometry (BD Biosciences,
United States). The fluorescence intensity of 10,000 gated
neutrophils was measured for each sample. The geometric
mean of the fluorescence intensity was calculated using FlowJo
software.
Murine Model of Intravenous Infection
An established murine model of S. aureus systemic infection
(Askarian et al., 2014) was utilized to identify the role of MVs
in promoting S. aureus survival in blood. Eight-week-old male
C57BL/6 mice (n = 10/group; Charles River, Wilmington,
MA, United States) were infected intravenously with
approximately 2 × 108 CFU S. aureus MSSA476 by tail vein
injection. PBS or MVs isolated from S. aureus MSSA476
grown in BHI (50 µg/mice) was added to the bacteria
resuspended in PBS and incubated for 30 min prior to the
injection of mice. The bacterial load in blood (CFU/ml) was
quantified at 24 h postinfection by plating serial dilutions
on THA.
Examination of Cell Viability
HaCaT cells, THP-1 cells, and neutrophils were seeded in either
12- or 96-well plates (Corning, United States) at confluent
concentrations. Cells were left untreated or treated with isolated
MVs. Thus, 5–20 µg MVs (0.025–0.1 µg/µl) were added to
neutrophils and THP-1 cells or 100 µg MVs (0.1 µg/µl) was
added to the HaCaT cells. The final volume was 200 and
1,000 µl in 96- and 12-well plates, respectively. Cell culture
supernatants were collected at the time points indicated and
centrifuged to pellet the cellular debris. Cellular cytotoxicity was
assessed by measuring the levels of lactate dehydrogenase (LDH;
Promega, United States) released by host cell into supernatant.
As an additional approach to visualize cell death, THP-1 cells
and neutrophils were stained with PI, which cannot penetrate
the intact host cell membrane. Representative live imaging was
performed by the Zeiss AxioObserver D1 microscope (Zeiss,
Germany).
NET Induction Assay
Freshly isolated neutrophils were seeded in 96-well plates
at a density of 2 × 105 cells/well in Hank’s balanced salt
solution (HBSS) supplemented with calcium and magnesium.
The cells were left untreated or treated with 20 µg MVs
(0.1 µg/µl) and incubated for at least 3 h at 37◦C with 5% CO2.
Additionally, the chemical neutrophil extracellular trap (NET)
inducer phorbol 12-myristate 13-acetate (PMA; Sigma–Aldrich,
Germany) was added to wells where applicable. Micrococcal
nuclease was then added to the wells before an additional 10 min
incubation at 37◦C. Micrococcal nuclease activity was stopped
by the addition of 5 mM EDTA to each well, and plates were
centrifuged at 200 × g for 8 min prior to collecting supernatant.
The extracellular DNA content in the supernatant was then
quantified using a Quant-IT PicoGreen dsDNA Assay kit (Life
Technologies, CA, United States) according to the manufacturer’s
instructions.
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NET Visualization by Fluorescence
Microscopy
Neutrophils were seeded in 96-well plates at a density
of 5 × 104 cells/well. NET production was induced as
described above and the cells were fixed by the addition of
paraformaldehyde (final concentration of 4%) followed by a
20 min incubation at room temperature. The cells were blocked
with PBS supplemented with 2% bovine serum albumin and
2% goat serum. Thereafter, the cells were immune-stained
using rabbit anti-human myeloperoxidase primary antibody,
Alexa Fluor 488 goat anti-rabbit immunoglobulin G secondary
antibody (Life Technologies, United States) and Hoechst-33342-
trihydrochloride (Life Technologies, United States) as previously
described (Corriden et al., 2015). Imaging was performed by the
Zeiss AxioObserver D1 microscope (Zeiss, Germany).
Degranulation of Neutrophils Quantified
by Elastase Release
The elastase release was performed as previously described
with minor modifications (Fuchs et al., 2007). Briefly,
2 × 105 neutrophils/well were resuspended in HBSS
supplemented with calcium and magnesium, and seeded
into each well of a 96-well plate. The cells were left untreated
or treated with 20 µg MVs (0.1 µg/µl) or 0.02% Triton
X-100, which served as a positive control (Fuchs et al., 2007).
The plate was incubated for 1 h at 37◦C with 5% CO2 and
centrifuged at 200 × g for 8 min. Thereafter, degranulation
was measured by incubating 100 µl of supernatant with the
elastase substrate, N-(methoxysuccinyl)-Ala-Ala-Pro-Val 4-
nitroanilide (Sigma–Aldrich, Germany), for 30 min followed by
measurement of optical density 405 nm using a Multimode Plate
Reader (PerkinElmer, Enspire Alpha, United States).
ROS Production Assay
The reactive oxygen species (ROS) production assay was
performed as previously described (Corriden et al., 2015).
Briefly, 2 × 106 neutrophils/ml were incubated in buffer (HBSS
without calcium and magnesium; Gibco, Life Technologies,
United Kingdom) containing 10 mM 2′,7′-dichlorofluorescin
diacetate (Sigma–Aldrich, Germany) for 20 min at 37◦C with
gentle agitation. The neutrophils now containing a cell permeable
non-fluorescent probe were then centrifuged at 400 × g for
5 min and washed with buffer. The neutrophil suspension was
added to a flat bottom 96-well plate (2 × 105 cells/well). Cells
were then left untreated or treated with 20 µg MVs (0.1 µg/µl)
or PMA (positive control). Oxidation of the probe results
in fluorescence (product information Sigma–Aldrich), and the
fluorescence intensity (485 nm excitation, 530 nm emission) was
measured at 15 min intervals using a Multimode Plate Reader
over the course of 2 h.
In Vitro Production of Cytokines from
Eukaryotic Cells
The effect of purified MVs on the cytokine secretion by
HaCaT and THP-1 cells was evaluated using Bio-Plex ProTM
Human Cytokine 27-plex Assay (Bio-Rad, United States;
Henno et al., 2017) and Quantikine ELISA kit (R&D Systems
Inc., United States), respectively. Briefly, 1.5 × 106 HaCaT cells
were seeded in 12-well plates (Corning, United States) to the
final volume of 1,000 µl and 1 × 105 THP-1 cells were seeded
in 96-well plates (Corning, United States) to the final volume
of 200 µl. HaCaT (100 µg MVs, i.e., 0.1 µg/µl), THP-1 (20 µg
MVs, i.e., 0.1 µg/µl) and freshly purified neutrophils (5–20 µg
MVs, i.e., 0.025–0.1 µg/µl) were treated with MVs isolated from
S. aureus MSSA476 grown in LB or BHI media or left untreated.
Thereafter, the cells were incubated at 37◦C in a CO2 incubator
with 5% CO2.
The culture supernatants were collected at the time points
indicated and centrifuged at 4◦C 13,000 × g for 7 min to
pellet the cellular debris. The cytokines secreted into the culture
supernatants were measured using multiplex and ELISA kits
according to the manufacturer’s instructions. The range of
cytokine response and detection measured are presented in
Supplementary Figure 4.
Immunization of Mice with
S. aureus-Derived MVs
A murine model was employed to determine if S. aureus-
derived MVs are immunogenic facsimiles of their parental
bacteria. Ultimately, S. aureus MRSA (USA300) was chosen as
a model organism as we previously encountered difficulties with
inducing sustained bacteremia and death using MSSA476 in
BALB/c mice. Additionally, S. aureus MRSA (USA300) has been
well characterized to have strong immune evasive properties
and poses various clinical challenges (Pier, 2013). First, MVs
production by the MRSA was confirmed via TEM analysis
(results not shown). Next, 8-week-old female BALB/c mice
(Charles River, Wilmington, MA, United States) were injected
intraperitoneally (i.p.) with purified membrane vesicles obtained
from S. aureus USA300 MRSA grown in BHI broth at the
concentration of 100 µg/mice at week 1, followed by 50 µg/mice
at weeks 2 and 3 (n = 10; Figure 4A). The control mice were
treated with PBS (n = 10). One week after the last immunization,
mice were bled submandibularly. Lastly, sera were collected,
pooled and stored at −80◦C for analysis of antibody titers by
ELISA.
Antibody Response of Immunized Mice
The serum antibody response was measured 7 days following
the last immunization in control (i.e., PBS treated) and MV
immunized mice. Briefly, microtiter plates (Nunc, Denmark)
were coated with 30 µg MVs in coupling buffer (100 mM
carbonate/bicarbonate buffer pH 9.6, Sigma–Aldrich, Germany)
and incubated overnight at 4◦C. Wells were blocked with
blocking buffer consisting of 1% (w/v) HSA for 2 h at 37◦C
and washed with PBS supplemented with 0.05% (v/v) Tween
20. Thereafter, 100 µl of diluted serum in pre-warmed blocking
buffer were loaded in the plate and incubated for 1 h at room
temperature. Secondary HRP-conjugated anti-mouse IgG2a,
IgG2b, IgG1, and IgA (Southern Biotechnology Associates,
United States), as well as IgM and IgG (Bethyl, United States)
were added to the plate wells (100 µl of a 1/5,000 dilution
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in blocking buffer) and the plates were incubated for 1 h at
37◦C. The Multimode Plate Reader was then used to measure
absorbance at 450 nm.
Murine Model of Subcutaneous and
Intraperitoneal Infection
We employed established in vivo murine models of systemic
and skin infection to determine if immunization with S. aureus
derived-MVs was protective against a live bacterial challenge. For
systemic infection, the PBS (control)- or MV-immunized mice
were infected i.p. with 2× 109 CFU bacteria in exponential phase
(OD600 = 0.6). Observed mortality was recorded twice per day up
to 10 days postinfection. For the subcutaneous infection model,
PBS- or MV-immunized mice were infected intradermally on a
shaved flank with 2 × 108 CFU bacteria in the exponential phase
(OD600 = 0.6). Area measurements (mm2) of lesions (defined as
dermonecrotic areas) were carried out on day 3 postinfection.
Abscesses were excised, homogenized, serially diluted in PBS and
bacterial loads (CFU/abscess) were quantified.
The degree of protective immunity in each respective model
was determined by survival of the mice or enumerating the
bacterial load in immunized and unimmunized mice.
Ethical Approval
Human neutrophils were isolated from freshly drawn human
blood. All blood donors provided written informed consent.
Additionally, all human blood draws and ex vivo analyses were
performed in accordance with the ethical principles outlined in
the Helsinki Declaration, the UCSD Medical Ethics Committee,
and ethical approval of 2014/1653 REK North-Norway. Animal
studies were performed under the UCSD approved IRB protocol
S00227M, and in accordance with the rules and regulations
outlined by the UCSD Institutional Animal Care and Use
Committee.
Statistical Analysis
Data from in vitro/ex vivo assays were represented as the
means ± standard error of mean (SEM) of at least three
independent experiments. The data presented in Figure 2D is
expressed as mean ± SEM of two independent experiments
each performed in triplicate. Data from the in vivo experiments
expressed as mean ± SEM represent one experiment performed
with 10 mice/group (mean ± SEM). The statistical analysis was
performed using pooled data for each experiment. Student’s t-test
or two-way ANOVA was used for determination of statistically
significant differences between groups (P < 0.05). Graphs were
generated using Excel or Graph Pad Prism.
RESULTS
S. aureus-Derived MV Varies in Size and
Associated Proteins Depending on
Growth Conditions
A TEM-immunogold staining of the methicillin-sensitive
hypervirulent community-acquired S. aureus strain MSSA476
demonstrated MV-release from bacteria grown in vitro on LA
and blood agar plates (Figure 1A). The gold particles (shown as
black dots) indicate the presence of peptidoglycan/peptidoglycan
precursors (white arrows) on the released MVs (black arrows)
from the bacterium. Different growth conditions influence the
expression of S. aureus virulence factors (Oogai et al., 2011;
Chaves-Moreno et al., 2016). However, whether changing growth
environment could influence the S. aureus MV cargo and
functions remain elusive, and these were our research questions.
Thus, MVs were studied in bacteria grown on enriched medium
containing host components such as hemoglobin (BHI and blood
agar) and a simpler medium (LB). First, AFM was performed
to analyze MV release from S. aureus strain MSSA476 grown
on LA, BHI and blood agar plates. MVs from S. aureus grown
on LA plates remained associated with the bacterial surface but
were also found in the surrounding environment (Figure 1B, left
panel and Supplementary Figure 5). Interestingly, the growth of
S. aureus on BHI or blood agar yielded an abundance of MVs
primarily in the surrounding environment (white arrow) or as
accumulated aggregates (yellow arrow; Figure 1B, middle and
right panels).
The size distributions of S. aureus MVs derived from bacteria
grown in both media were measured by dynamic light scattering.
The average size of MVs isolated from LB-grown bacteria
(46.6 ± 5.9 nm) was twofolds larger than MVs isolated from
the BHI-grown bacteria (24.4 ± 2.8 nm) (P < 0.05; Figure 1C).
Notably, MVs from the LB-grown bacteria also had a small
population of MVs with similar size as observed for MVs
produced by bacteria grown in BHI. Collectively, these results
demonstrate that the growth media can influence the size
distribution of MVs produced by S. aureus.
Next, we examined and compared the effect of different
growth conditions on MV-associated proteins. MVs isolated from
S. aureus grown in LB or BHI was further purified using a
differential centrifugation gradient to remove cellular debris and
contaminating proteins. Fractions were taken from the gradient
and analyzed on Coomassie Blue-stained SDS PAGE. The
fractions showing the same protein profile were pooled (examples
are shown in Supplementary Figure 2) and the MV purity
was verified by TEM negative staining (examples are shown
in Supplementary Figure 3A) and AFM imaging (examples are
shown in Supplementary Figure 3B). The quality/purity of the
MV preparation was also tested by immunogold labeling using
an antibody against the peptidoglycan epitope (Figure 1D). Our
results demonstrated purified MVs are densely covered with
peptidoglycan or peptidoglycan-precursors (Figure 1D). More
gold particles were detected in the purified MVs (Figure 1D)
compared to MVs released during in vitro bacterial culture on LA
or blood agar plates (Figure 1A), as the whole bacterial cells likely
compete with MVs to capture more peptidoglycan antibody.
Proteomic analysis was performed using an In-sol and a
LPI approach. The latter approach was utilized to increase the
chance of detecting surface-exposed proteins (Chooneea et al.,
2010; Karlsson et al., 2012). The resulting MS/MS spectra of
peptides identified in the S. aureus MVs were searched against
the genome of S. aureus MSSA476. A total of 131 and 617
proteins were identified in the MVs isolated from S. aureus
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FIGURE 1 | The size and protein cargo of S. aureus-derived MVs were markedly different depending on growth conditions. (A) TEM-immunogold analysis of
MV-generation on S. aureus MSSA476 (black arrow) grown on LA and blood agar plate. Gold particles (white arrows) indicate the presence of
peptidoglycan/peptidoglycan-precursors. The scale bar is shown. (B) Atomic force micrographs of S. aureus MSSA476 cultivated on LA, BHI- and blood agar
plates. Arrows indicate MVs on the bacterial surface and the released MVs. The scale bar is shown. (C) The average size distribution of MVs was determined using
dynamic light scattering. The data are expressed as mean ± SEM (standard error of the mean) of four independent measurements performed on independent
samples. (D) TEM-immunogold labeling of peptidoglycan/peptidoglycan-precursors in purified vesicles (black arrows) obtained from S. aureus MSSA476 grown in
BHI and LB purified by flotation through an OptiPrep density gradient. Gold particles (white arrows) indicate the presence of
peptidoglycan/peptidoglycan-precursors. Scale bars are shown. (E) S. aureus-derived vesicles from MSSA476 grown in LB and BHI were purified by flotation
through an OptiPrep density gradient. Venn diagram illustrates common and unique proteins associated with MV identified using LPI/in-solution approaches.
(F) Localization of the MV-associated proteins shown as the percentage in a pie chart. (G) Histograms representing the distribution of identified vesicular proteins
according to their molecular functions, role in biological processes and cellular components. (H) Supplementation of MVs (20 µg of total MV, i.e., 0.1 µg/µl) in the
culture media did not influence bacterial growth in LB media (left panel) or BHI (right panel). Data represent as the mean ± SEM of three independent experiments.
The significance is indicated by asterisks (∗): ∗∗P ≤ 0.01.
grown in the LB and BHI broth, respectively (Supplementary
Data Sheet 1). A comparative proteomic analysis was performed
to identify common or unique proteins associated with both
pools of S. aureus MVs. A total of 109 common proteins were
identified in the MSSA476 MVs isolated from both cultures,
whereas 22 and 508 proteins were uniquely associated with
the MVs from bacteria grown in LB vs. BHI, respectively
(Figure 1E). The overall distribution of expressed proteins in
MVs (Supplementary Figure 6 and Supplementary Data Sheet 2)
revealed that 46 of the identified proteins were found in MVs
isolated from both growth conditions and detection approaches
(Supplementary Figure 6, ABCD). However, all other proteins
were exclusively associated with one particular media condition
and/or identification method; 277 (A, BHI/LPI), 36 (B, BHI/in
solution), 9 (C, LB/LPI), and 7 (D, LB/in solution) proteins
(Supplementary Figure 6 and Supplementary Data Sheet 2).
Several known virulence-associated proteins and toxins were
identified in both pools of MVs (Table 1 and Supplementary
Data Sheets 1, 3). A quantitative proteomic analysis was
performed using the AUC to assess peptide abundance.
Formate acetyltransferase and delta-hemolysin precursor
were identified as the most abundant proteins in the
S. aureus MVs isolated from LB and BHI, respectively
(Supplementary Data Sheet 1). An in silico approach was
employed to identify lipoproteins and secretory signal peptides
in S. aureus-derived MVs. A large number of detected proteins
lack the signal peptide and lipobox motif (Supplementary Data
Sheet 3).
Identified MV proteins were classified according to
their estimated location in the bacterial cell (Figure 1F
and Supplementary Data Sheet 3). Cytoplasmic proteins
constituted the most abundant detected protein class (75.33%),
followed by proteins of unknown localization (10.4%)-,
cytoplasmic membrane proteins (5.3%)-, extracellular or
secreted proteins (5.3%), and cell wall-associated proteins (3.4%;
Figure 1F). Molecular functions, biological processes and cellular
components associated with the identified MV proteins were
categorized according to GO functions using the DAVID server
(Huang et al., 2009). According to molecular functions, the
majority of unique MV proteins isolated from bacteria grown
in BHI possessed either potential DNA/RNA/ATP binding
activities or ligase activities, while proteins from LB-derived
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TABLE 1 | Virulence factors associated with MVs isolated from S. aureus grown in BHI and LB.
GI accession no. Protein names Gene names Media
49243703 Alkyl hydroperoxide reductase subunit F ahpF BHI
49243704 Alkyl hydroperoxide reductase subunit C ahpC LB and BHI
49244335 Autolysin atl LB and BHI
49244621 Catalase katA LB and BHI
49244675 Conserved virulence factor B cvfB BHI
49245914 Collagen adhesin cna LB
49244100 Clumping factor A clfA LB and BHI
49245852 Clumping factor B clfB LB
49244762 Elastin-binding protein ebpS BHI
49244091 Enolase eno LB and BHI
49245254 Enterotoxin seq LB and BHI
49245208 Enterotoxin type A Sea LB
49245255 Staphylococcal enterotoxin Sek Sek2 LB
49245155 Ferritin ftnA LB and BHI
49245375 Putative non-heme iron-containing ferritin – BHI
49245643 Immunoglobulin-binding protein sbi sbi LB and BHI
49243431 Immunoglobulin G binding protein A precursor Spa LB and BHI
49244444 α-Hemolysin hly/hla LB
49245273 Delta-hemolysin hld LB and BHI
49245646 Gamma-hemolysin component A hlgA LB and BHI
49245645 Gamma-hemolysin component C hlgC LB
49245258 Putative leukocidin S subunit lukS LB and BHI
49245257 Putative leukocidin F subunit SAS1924 (lukF ) LB and BHI
49245789 O-acetyltransferase OatA oatA BHI
49244410 Iron-regulated surface determinant protein isdA LB and BHI
81696343 Iron-regulated surface determinant protein isdB LB and BHI
49245791 Immunodominant staphylococcal antigen A isaA BHI
49245611, 49243657 MarR family transcriptional regulator marR BHI
49245860 Immunodominant staphylococcal antigen B isaB LB
49244456 Phenol-soluble modulin beta 1 psmB1 BHI
49244216 Regulatory protein Spx spxA BHI
49244438 Extracellular fibrinogen binding protein efb LB and BHI
49243599 Peptidoglycan hydrolase lytM BHI
49245204 Staphylokinase sak LB
49243933 Staphylococcal accessory regulator A sarA BHI
49245519 Staphylococcal accessory regulator R sarR BHI
49243432 Staphylococcal accessory regulator S sarS BHI
49245749 Sortase A srtA BHI
49244001 HTH-type transcriptional regulator MgrA mgrA BHI
49243871 Bone sialo binding protein bbP LB and BHI
81696368 Serine-aspartate repeat-containing protein D sdrD LB
49245171 Staphopain A sspP LB
49244330 Staphopain B sspB LB and BHI
81649004 Staphylococcal complement inhibitor (SCIN) sciN LB
49245302 Serine-protein kinase RsbW (anti-sigma B factor) rsbW BHI
49245304 Putative sigma factor sigB regulation protein rsbU BHI
49244832 Superoxide dismutase sodA BHI
49243605 Staphylococcal Esx proteins (EsxA) esxA BHI
49245523 Staphylococcal secretory antigen ssaA2 ssaA2 BHI
49243983 HTH-type transcriptional regulator SarX sarX BHI
49243983 HTH-type transcriptional regulator rot rot BHI
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FIGURE 2 | Staphylococcus aureus MVs promote bacterial survival in human whole blood and in the presence of neutrophils ex vivo and in vivo. (A) Survival of
S. aureus MSSA476 in blood is increased in the presence of 20 µg MV (0.1 µg/µl) isolated from MSSA476 grown in LB and BHI [marked as LB (MVs) or BHI (MVs)
in the figure] compared to absence of MVs (marked as control in the figure). The number of inoculated bacteria at time point 0 was set to 100% and the number of
surviving bacteria after 3 h is represented as the percentage of inoculation. (B) S. aureus MSSA476 survival in blood is increased in the presence of MVs, in a
dose-dependent manner (5–20 µg of total MVs, i.e., 0.025–0.1 µg/µl). The number of surviving bacteria after 3 h in the absence of MVs was arbitrary set as 1, and
the number of surviving bacteria in the presence of MVs is represented as the fold change compared to bacteria in the absence of MV. (C) Survival of USA300 MRSA
in human blood is increased in the presence of MVs isolated from USA300 (MV-Hla) and USA3001Hla (MV-1Hla) grown in BHI. The percentage of survival was
calculated as described in (A). (D) Sonication of purified MVs followed by proteinase K (PK) treatment abolished the effect of MVs on bacterial survival in human
whole blood. The fold change of survival was calculated as described in (B). (E) Survival of opsonized S. aureus MSSA476 in the presence of neutrophils is
enhanced by supplementation of MVs isolated from bacteria growing in LB and BHI. Percentage of survival was calculated as described in (A). (F) S. aureus
MSSA476 were labeled with FITC and incubated with human whole blood in the absence or presence of MVs isolated from MSSA476 grown in LB and BHI. Data
represents geometric mean of the fluorescence intensity (GMFI). (G) Bacterial loads in the blood (CFU/ml) of 8-week-old C57BL/6 mice were counted 24 h after the
mice were intravenously infected with S. aureus MSSA476 supplemented with PBS or an exogenous source of MVs isolated from MSSA476 grown in BHI.
(H) HaCaT (100 µg of total MVs, i.e., 0.1 µg/µl) and freshly purified neutrophils were treated with MVs (5–20 µg of total MVs, i.e., 0.025–0.1 µg/µl) isolated from
S. aureus MSSA476 grown in LB or BHI at the time points indicated. Percentage of cytotoxicity was calculated by measuring the amount of LDH released from the
cytosol of damaged cells into the supernatant after exposure to MVs. (I) Viability staining of neutrophils in the presence (20 µg of total MVs, i.e., 0.1 µg/µl) or
absence of MVs were performed using propidium iodide (PI). Live imaging was performed after 0 and 0.45 or 1.5 h using fluorescence microscopy. Scale bar is
shown. The data represent as the mean ± SEM of at least three independent experiments except for (D), which the data are expressed as the mean ± SEM of two
independent experiments performed in triplicate. Mice study corresponds to one experiment performed with 10 mice/group. The significance is indicated by
asterisks (∗): ∗P < 0.05; ∗∗P ≤ 0.01; ∗∗∗P ≤ 0.001; ∗∗∗∗P ≤ 0.0001. ns, no significant difference.
MVs were enriched for endopeptidase activity (Figure 1G,
left panel). Various proteins found in both pools of MVs were
involved in crucial metabolic or virulence processes such as
carbohydrate synthesis or host cell cytolysis, while a major
component of unique MV proteins isolated from BHI was
associated with protein translation (Figure 1G, middle panel).
Moreover, the proteins within S. aureus-derived MVs could
be associated with different cellular components such as the
chromosome, cell surface, or ribosome (Figure 1G, right panel).
A significant portion of unique MV proteins isolated from
BHI was associated with ribosomes (Figure 1G, right panel).
Despite the presence of several proteins involved in bacterial
metabolism within MVs, media supplementation with an
exogenous source of purified MVs did not influence MSSA476
growth (Figure 1H).
In summary, all these results demonstrated different growth
conditions influence the size distribution and proteins associated
with MVs produced by S. aureus.
Exogenous MVs Increased Resistance of
S. aureus to Whole Blood and Neutrophil
Killing
Both pools of MVs contained several virulence factors (Table 1)
with proven or postulated roles in promoting S. aureus
survival in human blood (Malachowa and DeLeo, 2011;
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Thomer et al., 2016). To test this experimentally, S. aureus was
incubated in 80% freshly drawn human blood in the absence
or presence of exogenously administered MVs. As shown
in Figure 2A, MVs strongly promoted S. aureus MSSA476
survival in blood, in a dose-dependent manner (Figure 2B).
The MV-mediated increase in bacterial survival in human blood
was confirmed in the methicillin-resistant S. aureus USA300
(Figure 2C and Supplementary Figure 7A). Moreover, the
increased survival in blood was independent of α-hemolysin
(Hla) (Figure 2C and Supplementary Figure 7A), one of the
pore-forming toxins identified in the proteomic analysis (Table 1
and Supplementary Data Sheet 1). Next, we evaluated whether
MV-associated proteins are required for the observed MV-
mediated increased bacterial survival. In additional experiments,
MVs were sonicated and left untreated, or treated with PK
to degrade MV-associated proteins before being used as a
supplement in whole blood assay. As shown in Figure 2D and
Supplementary Figure 7B, the MVs with intact proteins increases
bacterial survival, while PK treated MVs completely abolished the
protective effect previously observed. These results underscore
the ability of the MV cargo to protect the pathogen from being
killed by components of human blood.
We next assessed whether S. aureus MVs confer resistance to
neutrophils, the most abundant leukocyte present in whole blood.
S. aureus was then co-incubated with purified human neutrophils
in the absence or presence of exogenously administered MVs
derived from bacteria grown in LB or BHI. Once again
despite differences in the MV protein content, both pools of
MVs significantly promoted resistance of S. aureus to human
neutrophil killing (Figure 2E). MV promotion of S. aureus
survival in blood could not be explained by differences in
neutrophil phagocytosis per se, as uptake of S. aureus by
human neutrophils within whole blood was comparable in the
presence and absence of MVs when assessed by flow cytometry
(Figure 2F). Currently, no S. aureus strain deficient in the
ability to generate MVs is known. Therefore, we employed a
murine intravenous infection model in the presence or absence of
supplemental MVs to evaluate the influence of MV on bacterial
survival in vivo by assessing the bacterial load from blood
and homogenized kidney, spleen, and liver 24 h postinfection.
As shown in Figure 2G, increased S. aureus recovery was
observed from mice infected with bacteria supplemented with
MVs compared to the control. In contrast, bacterial loads in the
kidney, spleen, and liver did not differ significantly between mice
infected with S. aureus supplemented with MV compared with
mice infected with S. aureus alone (Supplementary Figure 8).
These findings suggest exogenous MVs increase bacterial
survival in whole blood and within neutrophils. Our proteomic
analysis indicated that S. aureus MVs contained several cytolysins
and toxins (Table 1 and Supplementary Data Sheet 1) with
the potential for cytotoxic activity against host immune cells.
We next explored whether S. aureus MVs could influence
neutrophil viability and subsequently increase resistance to
neutrophil killing. Cytotoxicity of S. aureus MVs to neutrophils
was evaluated in vitro through LDH release at various time
points (Figure 2H). The viability of human neutrophils
decreased dramatically following even short-term exposure to
low concentrations of S. aureus-derived MVs (0.025 or 0.1 µg
total protein/µl; Figure 2H, right panel). MVs with high protein
diversity, derived from S. aureus grown in BHI, resulted in
significantly higher cytotoxicity in neutrophils following brief
exposure (0.2 h) to MVs (0.1 µg total protein/µl) compared
to those derived from LB culture. However, longer exposures
to both sources of MVs were associated with comparable levels
of cytotoxicity as measured by LDH released (Figure 2H,
right panel). The marked reduction in viability of neutrophils
exposed to S. aureus-derived MVs were also confirmed
by fluorescence microscopy using PI cell viability staining
(Figure 2I). Remarkably, the MVs also promote extensive
MV-induced cell death in the macrophage THP-1 cell lines
(Supplementary Figure 9), while it exhibited minimal cytotoxicity
to keratinocytes (HaCaT) even after 24 h exposure (Figure 2H,
left panel).
Together these results suggest exogenously added MVs
containing intact proteins improves the survival of S. aureus in
the presence of blood and purified neutrophils.
S. aureus-Derived MVs Possess
Neutrophil-Activating Properties
As the S. aureus derived-MVs markedly affected neutrophil
viability, the propensity of the MVs to induce NETs, a
consequence of a specialized form of neutrophil death
(Brinkmann et al., 2004), was assessed. NETs were analyzed
by immunostaining of untreated (control) or MV-treated
neutrophils using a primary antibody against myeloperoxidase
(a NETs marker) (Papayannopoulos et al., 2010; Figure 3A)
and by quantification of extracellular DNA release (Figure 3B).
Both approaches demonstrated the presence of MVs induced
NET release. PMA-treated and untreated neutrophils served as
positive and negative controls for NET formation, respectively
(Figure 3B). In addition, a release of the neutrophil degranulation
marker elastase into the cell culture supernatant was increased
upon exposure of neutrophils to S. aureus-derived MV compared
to untreated neutrophils (Figure 3C). These studies revealed that
MVs strongly stimulated NET production from freshly isolated
human neutrophils. Next, we evaluated whether the observed
MV-induced NET formation was dependent on ROS, which can
be measured by oxidation of a DCFH-DA probe. The positive
control, PMA, induced NET in a ROS-dependent manner, while
MV-induced NET-induction appeared to be independent of ROS
(Figure 3D). An additional approach was also employed, where
the ROS formation was inhibited by the scavenger BHA. Still,
MVs could induce NET formation, confirming its independence
of ROS (Figure 3E), while BHA inhibited PMA-induced NET
formation as expected (Figure 3E).
Our data demonstrate that S. aureus-derived MVs activate
neutrophils independent of ROS and induce the formation of
NETs.
Mice Immunized with MVs Are Protected
against S. aureus Challenge
MV-associated peptidoglycan (Figure 1D) and multiple cell-wall
attached/surface antigens (Table 1 and Supplementary Data
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FIGURE 3 | Staphylococcus aureus MVs promote extracellular trap formation in human neutrophils in vitro independent of ROS generation. Neutrophils were
incubated with PBS (control) or MVs isolated from bacteria grown in LB or BHI. NET induction was evaluated using various approaches: (A) Immunostaining using a
primary antibody against myeloperoxidase (green). The nucleus is stained with Hoechst (blue). Scale bar is shown. (B) Quantification of extracellular DNA and (C)
measuring neutrophils degranulation through determining the elastase release. The absorbance at 405 nm in the absence of MVs (control) was normalized to 1, and
the absorbance in the presence of MVs (LB and BHI) and the positive control (Triton) is represented as the fold change of elastase release. (D) DCF-based ROS
assays were performed to evaluate the effect of S. aureus MSSA476 MVs on ROS production by neutrophils. (E) Neutrophils were pre-treated with the ROS
scavenger BHA for 30 min before addition of either PMA or MSSA476 MVs to determine whether MVs induced NET production. Data represent as the mean ± SEM
of at least three independent experiments. The significance is indicated by asterisks (∗): ∗∗P ≤ 0.01; ∗∗∗P ≤ 0.001; ∗∗∗∗P ≤ 0.0001.
Sheet 1; Lee et al., 2009; Gurung et al., 2011; Jeon et al., 2016) may
induce a protective antibody response. Additionally, S. aureus-
derived MVs elicit a strong proinflammatory host response
(Supplementary Figures 10, 11; Hong et al., 2011; Kim et al.,
2012; Jun et al., 2017), which might provide an adjuvant effect.
To study if vaccination with MVs elicited a significant host
humoral immune response, mice were vaccinated i.p. with MRSA
USA300-derived MVs (Figure 4A). No mortality was observed
as a consequence of the vaccination protocol. One week after
completion of the last immunization, serum was collected, and
total anti-MV immunoglobulin levels were evaluated using a
competitive ELISA. A sharp increase in IgM, total IgG and
IgG subclasses (IgG1, IgG2a, and IgG2b) recognizing MVs
was measured in the serum of MV-immunized mice compared
to PBS-treated control mice (P < 0.05; Figure 4B). These
finding indicate a robust antibody response to MV vaccination.
Levels of IgA, an antibody involved in the immune defense of
mucous membranes, remain unchanged despite intraperitoneal
vaccination process (Figure 4B).
In order to test the effect of immunization, MV-immunized
mice were challenged with S. aureus using established murine
systemic and skin infection models. Vaccination with MVs
significantly improved mouse survival and recovery after lethal
challenge with USA300 MRSA (P < 0.05; Figure 4C). In a
localized skin abscess infection model, bacterial loads from
excised abscesses were significantly reduced in MV-immunized
mice compared to control mice, 3 days postinfection (Figure 4D,
left panel). However, no significant difference in lesion or abscess
size was identified between two groups (Figure 4D, right panel).
In summary, immunization of mice with S. aureus-derived
MVs elicited high anti-MV antibody titers and conferred
protection against S. aureus infection.
DISCUSSION
Staphylococcus aureus produces spherical, bi-layered MVs during
growth in vitro (Lee et al., 2009; Gurung et al., 2011) and in vivo
(Gurung et al., 2011). In our study, S. aureus was observed to
produce spherical MVs (Figures 1A,B) of varying size under
different in vitro growth conditions (LB vs. BHI; Figure 1C),
which are smaller than the Gram-negative OMVs (Lee et al.,
2009; Gurung et al., 2011). Moreover, the heterogeneity within
the size distribution obtained from isolated MVs from bacteria
growing in LB may suggest S. aureus produces two different
types of MVs under a nutrient-limited conditions (Figure 1C).
The growth media also influenced proteins associated with
S. aureus-derived MVs (Figure 1E and Supplementary Data
Sheets 1, 2), the respective biological processes they possessed
(Figure 1G), which was consistent with other studies (Lee
et al., 2009; Gurung et al., 2011; Jeon et al., 2016). Several
adhesins were identified through proteomic analysis of the
S. aureus MVs (Table 1), which suggest a role for MVs in
bacterial adhesion, colonization and tissue invasion. In addition,
the presence of a substantial number of proteins lacking a
signal peptide (Supplementary Data Sheet 3) suggests the
importance of MVs for releasing S. aureus virulence factors and
effector molecules. Although cell lysis was recently suggested
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FIGURE 4 | MVs-immunized mice developed IgM and IgG subclasses and were protected against live S. aureus MRSA challenge. MVs were isolated from MRSA
grown in BHI. (A) The diagram represents timeline for vaccination procedure and S. aureus challenges. (B) Titers of anti-MVs IgM, IgA, IgG, and of IgG subclasses
IgG1, IgG2a, and IgG2b were measured in female BALB/c mice immunized intraperitoneally with MRSA-derived MVs or with PBS. Serum was collected as depicted
in (A). (C) Percentage of survival of PBS- and MVs-immunized mice, which were challenged intraperitoneally with S. aureus. (D) Bacterial load per skin abscess (left
panel) and abscess size (right panel) was measured in PBS- and MV-immunized mice 3 days after subcutaneous infection. Data correspond to one experiment
performed with 10 mice/group (mean ± SEM). The significance is indicated by asterisks (∗): ∗P < 0.05. ns, no significant difference.
as a putative mechanism for MV biogenesis in Gram-negative
(Turnbull et al., 2016) and Gram-positive bacteria (Toyofuku
et al., 2017), it is likely that other mechanisms of MV release
also exists (Brown et al., 2015; Orench-Rivera and Kuehn,
2016). Indeed, a strong association between MV generation
and bacterial viability has been demonstrated in the Gram-
positive strain, Streptococcus pneumoniae (Olaya-Abril et al.,
2014). Thus, the presence of several cytoplasmic markers,
e.g., Ldh, GyrB, etc, in the MV cargo (Supplementary Data
Sheets 1–3) could be due to the fact that a part of the
cytoplasm is trapped during MV biogenesis. Moreover, the
presence of proteins involved in peptidoglycan-based cell wall
biogenesis or cell wall organization properties, e.g., FemA,
FemB, LytM, etc. (Table 1 and Supplementary Data Sheets 1–
3) and detection of peptidoglycan or peptidoglycan-precursors
associated with S. aureus-derived MVs (Figures 1A,D) suggests
that the cell wall is altered during MVs release (Lee et al.,
2009).
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Staphylococcus aureus is a leading cause of bloodstream
infection and survives in the host via multiple mechanisms
avoiding clearance by components of the innate immune
system (Malachowa and DeLeo, 2011). Here we found that
exogenously administered MVs promoted bacterial survival in
an ex vivo whole blood model (Figures 2A,B). The effect
was abolished when MVs were sonicated and pre-treated with
PK (Figure 2D and Supplementary Figure 7B), suggesting
MV-associated proteins are involved in increased bacterial
survival in blood. A tight association of biologically active
pore-forming α-hemolysins in S. aureus-derived MVs and
cytotoxicity has been previously demonstrated (Thay et al.,
2013). α-Hemolysin, was identified using proteomic analysis of
our S. aureus-derived MVs (Table 1 and Supplementary Data
Sheets 1, 3) and in earlier studies (Lee et al., 2009; Gurung
et al., 2011). However, in our study, α-hemolysin did not
influence bacterial survival in blood as USA300 treated with
the MVs from the isogenic mutant survived as efficiently as
the wild-type (Figure 2C and Supplementary Figure 5A). Many
other key virulence factors are involved in the pathogenesis of
S. aureus during bloodstream infections (reviewed in Thomer
et al., 2016), and several of them were identified in the
MVs (Table 1 and Supplementary Data Sheets 1–3). These
proteins may have contributed to the increased bacterial
survival observed in blood. A certain level of MVs seems
to be required to aid pathogen survival in blood as no
significant effect was observed with low doses of MVs (5 µg;
Figure 2B).
Purified MVs were highly cytotoxic to freshly isolated
neutrophils (Figures 2H,I), which might be due to the abundance
of known S. aureus leukocyte-specific toxins in the MV cargo
(Table 1; Lee et al., 2009; Gurung et al., 2011; Jeon et al., 2016).
We also found that S. aureus-derived MVs could induce NET
formation independent of ROS generation (Figure 3), consistent
with recent observations that this cell death pathway can
sometimes be elicited without oxidative burst activation (Pilsczek
et al., 2010; Corriden et al., 2015; and reviewed in Remijsen
et al., 2011). The Panton–Valentine leukocidin components,
LukF and LukS have previously been identified as the dominant
NET inducer in the bacterial culture supernatant (Pilsczek
et al., 2010). Interestingly, LukF and LukS were detected in the
S. aureus-derived MVs through proteomic analysis (Table 1 and
Supplementary Data Sheets 1–3), which might partly explain
MVs NET induction.
Both pools of MVs carry lipoproteins (Supplementary
Data Sheet 3), peptidoglycan-precursors (Figure 1D) and cell
wall-anchored proteins (Table 1 and Supplementary Data
Sheets 1–3). Purified S. aureus MVs derived from bacteria
grown in the two different media induced comparable levels
of cytokine responses. Lipoproteins yield an excessive host
inflammatory response (Kovacs-Simon et al., 2011; Shahmirzadi
et al., 2016), while peptidoglycan (Capparelli et al., 2011)
or a combination of surface antigens (Stranger-Jones et al.,
2006) has been suggested to provide protective immunity
against a lethal challenge in experimental in vivo studies.
Cytokine stimulation by S. aureus-derived MVs (Supplementary
Figures 10, 11; Hong et al., 2011; Kim et al., 2012; Jun et al.,
2017) combined with a rich cargo of various proteins/antigens
(Table 1 and Supplementary Data Sheets 1–3; Lee et al., 2009;
Gurung et al., 2011; Jeon et al., 2016) and detection of
peptidoglycan or peptidoglycan-precursors (Figure 1D)
suggest that these purified cell-free components might
represent a vaccine candidate. Indeed, mice immunized
with MVs had increased antigen-specific IgM and IgG
levels (Figure 4B) and showed significantly attenuated
lethality and bacterial load after systemic and subcutaneous
infection, respectively (Figures 4C,D), compared to all sham
(PBS)-immunized mice, which died within 4 days in our
studies.
We further evaluated IgG isotype levels, as their nature can
affect the FcγRs engagement by immune cells and subsequent
leukocyte activities (Nimmerjahn and Ravetch, 2005; Bournazos
et al., 2015). A robust induction of IgG subclasses including IgG1,
IgG2a, and IgG2b antibodies was observed in MV-immunized
mice (Figure 4B). The role of different IgG isotypes in combating
S. aureus infections is not well understood. However, the IgG2a
isotype has been shown to provide greater protection than IgG1
or IgG2b against staphylococcal enterotoxin B-induced lethal
shock in murine sepsis models (Varshney et al., 2014). IgG2a
also plays an important role in complement activation and
phagocytosis by neutrophils (Nimmerjahn and Ravetch, 2005;
Bournazos et al., 2015). Skin application of S. aureus-derived
MVs has been shown to promote antibody and T cell-mediated
immune responses (Hong et al., 2011), and a Th1-mediated
cellular response was implicated in the protection of mice against
staphylococcal lung infection as result of MV immunization
(Choi et al., 2015).
In summary, our study revealed that growth conditions
influence the size and proteome of S. aureus-derived MVs.
Both pools of MVs elicited similar effects on selected host
cellular responses despite the clear diversity of their associated
proteome. The type of host response induced by MVs is clearly
influenced by bacterial strains, the amount of MVs used and the
content of virulence factors (reviewed in Lee, 2012; Kaparakis-
Liaskos and Ferrero, 2015; Schwechheimer and Kuehn, 2015).
The comparable response induced by MSSA476 MVs isolated
from bacteria grown in LB and BHI may highlight the importance
of the common proteins. The MVs induced a proinflammatory
response, and immunization of mice resulted in IgM and IgG
responses that attenuated the burden of S. aureus infection.
Our findings underscore the role of S. aureus-derived MVs
and its noxious cargo in bacterial pathogenesis, its interactions
with the host immune system and their potential for further
exploration as a vaccine candidate.
CONCLUSION
The ubiquitous release of MVs by both Gram-positive and
Gram-negative bacteria is consistent with other bacterial
secretion systems. Although the mechanism of MVs biogenesis
in Gram-positive bacteria is not fully understood, targeting this
conserved process could be a powerful approach for altering
complex host–pathogen interactions. Further investigation of
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bacterial MV generation under host mimicking conditions will
better reveal their importance and associated virulence in human
infections. MVs have immunogenic properties, which can be an
advantage in vaccine design. However, several issues need to be
addressed before they can be developed into therapeutic agents
and vaccines.
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